News | April 06, 2026
Samsung Biologics lands first US manufacturing facility with GSK acquisition
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
Company leadership is framing the move as transformational.
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
Ac-225, an alpha-emitting radionuclide, can be paired with molecules designed to selectively target cancer cells.
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
This follows a $6 million expansion in Rosenberg in 2025 and signals a major push to boost commercial capacity, expand R&D capabilities, and meet rising demand for US-based drug product manufacturing
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
Subscribe To Our Newsletter & Stay Updated
